Huihui Chong

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Phosphorylation of shiftless is important for inhibiting the programmed -1 ribosomal frameshift.

Phosphorylation of shiftless is important for inhibiting the programmed -1 ribosomal frameshift.

Journal: Science advances

Published: December 19, 2025

Pharmacokinetics and safety of HIV fusion inhibitor Lipovirtide in non-human primates.

Pharmacokinetics and safety of HIV fusion inhibitor Lipovirtide in non-human primates.

Journal: Antiviral research

Published: November 04, 2025

Pharmacokinetics and safety of HIV fusion inhibitor Lipovirtide in non-human primates.

Pharmacokinetics and safety of HIV fusion inhibitor Lipovirtide in non-human primates.

Journal: Antiviral research

Published: November 04, 2025

Structural characterization of HIV fusion inhibitor LP-98: Insights into antiviral and resistance mechanisms.

Structural characterization of HIV fusion inhibitor LP-98: Insights into antiviral and resistance mechanisms.

Journal: Antiviral research

Published: April 08, 2025

Addition of a short HIV-1 fusion-inhibitory peptide to PRO 140 antibody dramatically increases its antiviral breadth and potency.

Addition of a short HIV-1 fusion-inhibitory peptide to PRO 140 antibody dramatically increases its antiviral breadth and potency.

Journal: Journal of virology

Published: March 25, 2025

An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques.

An HIV fusion-inhibitory lipopeptide provides robust post-exposure prophylaxis and prevents viral reservoir seeding in macaques.

Journal: Cell reports

Published: March 24, 2025

Pharmacokinetic and safety evaluation of lipopeptide-based HIV fusion inhibitor Lipovirtide in rats.

Pharmacokinetic and safety evaluation of lipopeptide-based HIV fusion inhibitor Lipovirtide in rats.

Journal: Antiviral research

Published: March 13, 2025

Development of lipopeptide-based HIV-1/2 fusion inhibitors targeting the gp41 pocket site with a new design strategy.

Development of lipopeptide-based HIV-1/2 fusion inhibitors targeting the gp41 pocket site with a new design strategy.

Journal: Antiviral research

Published: September 05, 2024

PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub.

PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub.

Journal: Nature communications

Published: June 27, 2024

Prolonged release and antiviral efficacy of HIV fusion inhibitor LP-98-loaded microspheres in rhesus macaques.

Prolonged release and antiviral efficacy of HIV fusion inhibitor LP-98-loaded microspheres in rhesus macaques.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 19, 2024

Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure.

Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure.

Journal: Microbes and infection

Published: April 03, 2024

Development of potent pan-coronavirus fusion inhibitors with a new design strategy.

Development of potent pan-coronavirus fusion inhibitors with a new design strategy.

Journal: MedComm

Published: October 11, 2023

Showing 1-12 of 64

Last Updated: 09/26/2026